Clinical Trials for Amryt Pharma

Explore 8 clinical trials worldwide

Showing 1-8 of 8 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Amryt Pharma

Clinical Trials (8)

Open-label Study to Evaluate Metreleptin in Children Under 6 Years of Age With Generalised Lipodystrophy

PHASE3Recruiting

15 participants

Started: May 23, 2025 · Completed: Sep 30, 2026

1 condition1 sponsor12 locations

A Study to Assess the Incidence of Skin Cancers in Patients With Epidermolysis Bullosa Receiving Filsuvez

580 participants

Started: Dec 18, 2024 · Completed: Aug 1, 2032

2 conditions2 sponsors5 locations

Open-label Extension Study to Evaluate Metreleptin in Patients With Partial Lipodystrophy

PHASE3Recruiting

15 participants

Started: Oct 14, 2024 · Completed: Mar 31, 2028

1 condition1 sponsor6 locations

Evaluation of the Effect of Lomitapide Treatment on Major Adverse Cardiovascular Events (MACE) in Patients With Homozygous Familial Hypercholesterolemia

72 participants

Started: Sep 9, 2024 · Completed: Dec 31, 2026

3 conditions4 sponsors30 locations

Open-label Study to Evaluate Metreleptin in Patients With Partial Lipodystrophy

PHASE4Recruiting

12 participants

Started: Feb 8, 2024 · Completed: Feb 29, 2028

1 condition1 sponsor12 locations

Evaluation of Safety and Efficiency of Metreleptin Treatment for Patients With Multiple Symmetric Lipomatosis (MSL)

PHASE2Active, not recruiting

Started: Aug 1, 2023 · Completed: Oct 31, 2028

1 condition2 sponsors1 location

Study to Evaluate the Safety and Efficacy of Daily Subcutaneous Metreleptin Treatment in Subjects With PL

PHASE3Active, not recruiting

69 participants

Started: Dec 17, 2021 · Completed: Oct 31, 2026

1 condition1 sponsor31 locations

LOWER: Lomitapide Observational Worldwide Evaluation Registry

300 participants

Started: Mar 18, 2014 · Completed: Sep 1, 2028

1 condition1 sponsor75 locations